Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-180.59%Shareholder Yield
VS
Market
Sector
Industry
History
$ 2.43Close
$ 2 - $ 29.07 52-Week Range
Ticker Information
Ticker
BBLGCompany Name
BONE BIOLOGICS CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQBONE BIOLOGICS CORP - Shareholder Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BBLG - Shareholder Yield Historical data
| Date | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
|---|---|---|---|---|---|
| 6/30/2025 | $ 4.22M | $ 7.62M | $ 0 | $ 0 | -180.59% |
| 3/31/2025 | $ 2.39M | $ 3.27M | $ 0 | $ 0 | -136.74% |
| 12/31/2024 | $ 3.08M | $ 4.42M | $ 0 | $ 0 | -143.74% |
| 9/30/2024 | $ 3.18M | $ 3.9M | $ 0 | $ 0 | -122.8% |
| 6/30/2024 | $ 3.04M | $ 2.1M | $ 0 | $ 0 | -68.86% |
| 3/31/2024 | $ 2.53M | $ 2.1M | $ 0 | $ 0 | -82.83% |
| 12/31/2023 | $ 1.68M | $ 5.04M | $ 0 | $ 0 | -299.74% |
| 9/30/2023 | $ 1.57M | $ 4.43M | $ 0 | $ 0 | -282.66% |
| 6/30/2023 | $ 3.92M | $ 4.43M | $ 0 | $ 0 | -113.06% |
| 3/31/2023 | $ 3.09M | $ 4.43M | $ 0 | $ 0 | -143.36% |
Key Performance Insights, Last 5 Years
- BONE BIOLOGICS CORP's latest trailing twelve months (TTM) Shareholder Yield stands at 0%.
- Over the past 5 years, BONE BIOLOGICS CORP's average Shareholder Yield has been -124.09%.
- The median Shareholder Yield for BONE BIOLOGICS CORP during this period was -117.93%
- BONE BIOLOGICS CORP reached its highest Shareholder Yield over the past 5 years at -2.98%.
- The lowest Shareholder Yield recorded by BONE BIOLOGICS CORP in the same timeframe -299.74%
Similar metrics to Shareholder Yield:
- Payout Yield - [Calculation] The Payout Yield describes the percentage a business is returning to its shareholders in the form of share buybacks and dividends.
- Buyback Yield - [Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
Definition of Shareholder Yield
[Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield Shareholder Yield for BONE BIOLOGICS CORP is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 402.79K ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ] BBLG - Shareholder Yield, Last 5 years
-299.74%
Minimum
Dec 31, 2023
-2.98%
Maximum
Sep 30, 2021
-124.09%
Average
-117.93%
Median
Shareholder Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Shareholder Yield for companies in the Total Stock Market. The average Shareholder Yield of the companies is 0.58% with a standard deviation of 11.13%.
The following table provides additional summary stats:
Shareholder Yield in the Market:
| filtered constituents | 3.48K |
|---|---|
| min | -33.43% |
| max | 34.45% |
| average | 0.58% |
| median | 1.07% |
| std | 11.13% |